Home » Products » Pharmaceutical Ingredients

Pharmaceutical Ingredients

Dextromethorphan Hydrobromide
close
Dextromethorphan Hydrobromide
5
Dextromethorphan Hydrobromide
Cefuroxime Axetil
close
Cefuroxime Axetil
Cefuroxime Axetil1
Ibuprofen Powder
close
Ibuprofen Powder
12
Ondansetron Hydrochloride Dihydrate IP USP BP EP
close
Ondansetron Hydrochloride Dihydrate IP USP BP EP
1521
manufacturer and exporter of Ondansetron Hydrochloride Dihydrate IP USP BP EP
ibuprofen DC
close
ibuprofen DC
manufacturer and exporter of ibuprofen DC
manufacturer and exporter of ibuprofen DC
Fluconazole IP USP BP EP
close
Fluconazole IP USP BP EP
1520
Fluconazole IP USP BP EP
Cefotoxime Proxetil
close
Cefotoxime Proxetil
08
Cefuroxime Axetil
close
Cefuroxime Axetil
9
Sildenafil Citrate
close
Sildenafil Citrate
10
Azithromycin trihydrate
close
Azithromycin trihydrate
13
Azithromycin trihydrate
Ibuprofen DC 90
close
Ibuprofen DC 90
15
PARACETAMOL DC 90
close
PARACETAMOL DC 90
16
Albendazole
close
Albendazole
17
Mebendazole
close
Mebendazole
18
Losartan Potassium
close
Losartan Potassium
20
ATORVASTATIN CALCIUM
close
ATORVASTATIN CALCIUM
22
valproic acid
close
valproic acid
23
sodium valproate
close
sodium valproate
23
Pantoprazole Sodium Sesquihydrate
close
Pantoprazole Sodium Sesquihydrate
23
Pantoprazole Sodium Sesquihydrate
ROSUVASTATIN CALCIUM
close
ROSUVASTATIN CALCIUM
23
Diclofenac Sodium
close
Diclofenac Sodium
24
doxycycline hydrochloride
close
doxycycline hydrochloride
25
doxycycline hydrochloride
Acetaminophen
close
Acetaminophen
26
ceftriaxone sodium
close
ceftriaxone sodium
27
valsartan USP
close
valsartan USP
28


Disclaimer
  • Above and attached product covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer only.
  • Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and liability for patent infringement is exclusively understood at buyer' risk.
Send Inquiry
Back to top